[Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6
Affiliations: Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Nanguan, Changchun, Jilin 13033, P.R. China, Department of Surgery, China-Japan Union Hospital of Jilin University, Nanguan, Changchun, Jilin 13033, P.R. China
- Published online on: May 31, 2021 https://doi.org/10.3892/or.2021.8097
- Article Number: 146
Copyright : © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 34: [Related article:] 2202-2210, 2015; DOI: 10.3892/or.2015.4165
Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that certain of the western blotting data shown in Figs. 4C, 5B and 6D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.